Liqiang Qian Selected Research

lupeol

10/2021	Retraction Note to: Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.
8/2021	Retraction Note to: Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.
12/2016	Lupeol Induces Apoptosis and Cell Cycle Arrest of Human Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway.
5/2016	Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.
1/2016	Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.
3/2015	Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liqiang Qian Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 03/2015
7	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2014
7	Carcinoma (Carcinomatosis) 10/2021 - 01/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2010
3	Hepatocellular Carcinoma (Hepatoma) 06/2016 - 11/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 03/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Adenocarcinoma 01/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020
1	Carcinogenesis 02/2018
1	Thymoma (Thymic Carcinoma) 07/2017
1	Osteosarcoma (Osteogenic Sarcoma) 12/2016
1	Colonic Neoplasms (Colon Cancer) 12/2016
1	Stomach Neoplasms (Stomach Cancer) 05/2016
1	Fibrosis (Cirrhosis) 01/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Cough 04/2014
1	Hemorrhage 04/2014
1	Tuberculoma 03/2010

Drug/Important Bio-Agent (IBA)

6	lupeolIBA 10/2021 - 03/2015
6	Proteins (Proteins, Gene)FDA Link 05/2020 - 04/2016
4	oxymatrineIBA 02/2018 - 06/2016
4	TriterpenesIBA 12/2016 - 03/2015
3	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 05/2016
2	imidazoleacetic acid (IMAC)IBA 01/2022 - 05/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2017
2	ProteomeIBA 08/2017 - 04/2016
2	Annexin A5IBA 12/2016 - 06/2016
2	Propidium (Propidium Iodide)IBA 12/2016 - 06/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 11/2015
2	MatrinesIBA 11/2015 - 01/2015
1	PhosphoproteinsIBA 05/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	bufalinIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	matrigelIBA 01/2020
1	graphene oxideIBA 05/2018
1	Carrier Proteins (Binding Protein)IBA 05/2018
1	Nucleic AcidsIBA 05/2018
1	PhytochemicalsIBA 02/2018
1	Biological ProductsIBA 08/2017
1	MicroRNAs (MicroRNA)IBA 02/2017
1	Methylnitronitrosoguanidine (MNNG)IBA 12/2016
1	Cyclin D1IBA 12/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2016
1	TOR Serine-Threonine KinasesIBA 12/2016
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 06/2016
1	RNA (Ribonucleic Acid)IBA 06/2016
1	Caspase 3 (Caspase-3)IBA 06/2016
1	Cytostatic AgentsIBA 01/2016
1	AlkaloidsIBA 11/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2015
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2015

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2020 - 03/2015
3	Chemoprevention 06/2016 - 03/2015
2	Segmental Mastectomy (Lumpectomy) 01/2022 - 04/2013
2	Length of Stay 07/2017 - 04/2014
2	Lymph Node Excision (Lymph Node Dissection) 04/2014 - 03/2010
1	Immunotherapy 01/2022
1	Sternotomy 07/2017
1	Thymectomy 07/2017
1	Therapeutics 12/2016
1	Adjuvant Chemotherapy 05/2016
1	Intravenous Administration 11/2015